A blog about what is new (and old) in the world of active implantable medical devices 

Facebook Twitter Gplus Flickr LinkedIn YouTube RSS
magnify
Home Therapies Neural Stimulation Archive for category "Vagus Nerve Stimulation"
formats

EnteroMedics Reports Maestro Obesity Study Showing 25% Reduction in Excess Weight

EnteroMedics reported new clinical trial data for its Maestro system, which is designed to treat obesity through vagus nerve stimulation. The company said that its Maestro RC system lost 25% of their excess weight, or 10% of their total body weight, after 18 months. Patients who received a sham implant lost 12% of excess weight,

 
 Share on Facebook Share on Twitter Share on Reddit Share on LinkedIn
Comments Off on EnteroMedics Reports Maestro Obesity Study Showing 25% Reduction in Excess Weight  comments 
formats

Cerbomed’s Non-Invasive Vagus Nerve Stimulator Poses Challenge to Implantable VNS Systems

Cerbomed GmbH, located in Erlangen, Germany, was founded in 2005 to develop transcutaneous Vagus Nerve Stimulation (t-VNS®) neuromodulation systems. Surgically accessing the Vagus Nerve is not trivial, and implanting a VNS system involving cuff electrodes is risky and recovery is lengthy.  Enter t-VNS, which is delivered non-invasively to the auricular branch of the vagus nerve (ABVN), making

 
 Share on Facebook Share on Twitter Share on Reddit Share on LinkedIn
Comments Off on Cerbomed’s Non-Invasive Vagus Nerve Stimulator Poses Challenge to Implantable VNS Systems  comments 
formats

European Heart Rhythm Association Issues Very Interesting Report on New Devices for the Treatment of Heart Failure

  A position paper was published yesterday by the European Heart Rhythm Association reporting on the performance of new devices for the treatment of heart failure (HF). The report has been endorsed by the Heart Failure Association. The abstract for the paper titled “New devices in heart failure: an European Heart Rhythm Association report” reads:

 
 Share on Facebook Share on Twitter Share on Reddit Share on LinkedIn
Comments Off on European Heart Rhythm Association Issues Very Interesting Report on New Devices for the Treatment of Heart Failure  comments 
formats

MicroTransponder Raises Funds for Clinical Trials of Serenity VNS IPG for Treating Tinnitus

MicroTransponder, Inc. of Dallas, TX has raised $3.4 million to carry out clinical trials of its Vivistim System to help restore functionality in the upper limbs of stroke patients, and its Serenity System designed to “rewire” the auditory cortex of tinnitus patients. The company intends to secure a CE mark for both systems next year, and then

 
 Share on Facebook Share on Twitter Share on Reddit Share on LinkedIn
Comments Off on MicroTransponder Raises Funds for Clinical Trials of Serenity VNS IPG for Treating Tinnitus  comments 
formats

ElectroCore’s Noninvasive Vagus Nerve Stimulation – An Interesting Challenge to Implantable VNS Systems

Surgically accessing the Vagus Nerve is not trivial, and implanting a VNS system involving cuff electrodes is risky and recovery is lengthy.  Enter ElectroCore Medical of Bernards Township, New Jersey – it is developing non-invasive VNS therapies that treat or prevent symptoms of serious headache conditions, including migraines and cluster headaches, and bronchoconstriction including asthma and chronic obstructive

 
 Share on Facebook Share on Twitter Share on Reddit Share on LinkedIn
Comments Off on ElectroCore’s Noninvasive Vagus Nerve Stimulation – An Interesting Challenge to Implantable VNS Systems  comments 
formats

Interesting 2012 Presentation by Setpoint Medical on Neuromodulation for Treating Chronic Inflammatory Diseases

I found online the PowerPoint presentation for: R Zitnik, Y Levine, M Faltys, T Arnold, “Harnessing the Inflammatory Reflex: Using Neuromodulation as a Novel Approach to Treat Chronic Inflammatory Diseases”, North American Neuromodulation Society Meeting 2012. The presentation shows some preliminary animal results, presents an artist’s conception of the implantable system, and concludes as follows:

 
 Share on Facebook Share on Twitter Share on Reddit Share on LinkedIn
Comments Off on Interesting 2012 Presentation by Setpoint Medical on Neuromodulation for Treating Chronic Inflammatory Diseases  comments 
formats

Cyberonics Reports 12.4% Increase in VNS Sales for Fiscal Q1 2014

Net product sales increased 12.4% to $67.4 million in the first fiscal quarter ended July 26 for Cyberonics, Inc. of Houston, TX. Including license revenue, sales were up 14.2% overall, with Europe in particular contributing a strong performance. Diluted earnings per share were adjusted by $0.17 cents due to a litigation settlement. According to the

 
 Share on Facebook Share on Twitter Share on Reddit Share on LinkedIn
Comments Off on Cyberonics Reports 12.4% Increase in VNS Sales for Fiscal Q1 2014  comments 
formats

SetPoint Medical Secures $27M to Develop VNS Device to Treat Inflammatory Diseases

SetPoint Medical, headquartered in Valencia, California, is developing neuromodulation therapies for patients with inflammatory autoimmune diseases, such as rheumatoid arthritis (RA), inflammatory bowel disease (IBD), psoriasis, diabetes, heart disease, and multiple sclerosis. SetPoint’s proprietary neuromodulation platform consists of an implantable “microregulator”, wireless charger and iPad prescription pad application. SetPoint announced today that it has secured

 
 Share on Facebook Share on Twitter Share on Reddit Share on LinkedIn
Comments Off on SetPoint Medical Secures $27M to Develop VNS Device to Treat Inflammatory Diseases  comments 
formats

Neurotech’s ADNS-300 Rechargeable Vagus Nerve Stimulator IPG for Epilepsy

In June 2012 Neurotech s.a. (http://www.neurotech-int.eu), a Belgium based developer and manufacturer of neurostimulation devices, obtained the CE Mark for its ADNS-300 system for the treatment of refractory epilepsy. According to the press release: “Advens therapy” uses the ADNS-300 stimulator as a therapeutic option for those patients who are refractory to anti-epileptic drugs and are not

 
 Share on Facebook Share on Twitter Share on Reddit Share on LinkedIn
Comments Off on Neurotech’s ADNS-300 Rechargeable Vagus Nerve Stimulator IPG for Epilepsy  comments 
formats

SetPoint Medical’s Vagus Nerve Stimulation for Treatment of Systemic Inflammation

SetPoint Medical, headquartered in Valencia, California, is developing neuromodulation therapies for patients with inflammatory autoimmune diseases, such as rheumatoid arthritis (RA), inflammatory bowel disease (IBD), psoriasis, diabetes, heart disease, and multiple sclerosis.  SetPoint’s proprietary neuromodulation platform consists of an implantable “microregulator”, wireless charger and iPad prescription pad application.

 
 Share on Facebook Share on Twitter Share on Reddit Share on LinkedIn
Comments Off on SetPoint Medical’s Vagus Nerve Stimulation for Treatment of Systemic Inflammation  comments 
formats

EnteroMedics Reports $123k Revenue from Sales of its Maestro RC IPG for Treatment of Obesity

Today EnteroMedics recorded revenue for the first time since it was incorporated nearly eight years ago. The company reported revenue of about $123,000 in the first quarter of the year from the sale of its Maestro RC implantable vagus nerve stimulation system for treating obesity. Revenue was generated through sales by its distribution partner in Australia.

 
 Share on Facebook Share on Twitter Share on Reddit Share on LinkedIn
Comments Off on EnteroMedics Reports $123k Revenue from Sales of its Maestro RC IPG for Treatment of Obesity  comments 
formats

BioControl’s CardioFit System for the Treatment of Heart Failure via Vagus Nerve Stimulation

BioControl Medical, Ltd. was founded in 1999 by Yossi Gross, and is based in Yehud, Israel.  BioControl’s first devices were developed to treat incontinence due to overactive bladder, stress, and interstitial cystitis.  In 2006 American Medical Sytems acquired an exclusive license for the use of the technology in urology, gynecology and other pelvic health applications.

 
 Share on Facebook Share on Twitter Share on Reddit Share on LinkedIn
Comments Off on BioControl’s CardioFit System for the Treatment of Heart Failure via Vagus Nerve Stimulation  comments 
formats

CCC Medical – Top OEM to AIMD Start-Ups

CCC is one of the oldest pacemaker manufacturers in the world. It was founded in 1969 by Dr. Orestes Fiandra, who performed the first succesful, human, long-term pacemaker implant in the world. This was achieved in Uruguay on February 2, 1960 by Dr. Orestes Fiandra and Dr. Roberto Rubio. The pacemaker was manufactured by Dr. Rune Elmqvist of

 
 Share on Facebook Share on Twitter Share on Reddit Share on LinkedIn
Comments Off on CCC Medical – Top OEM to AIMD Start-Ups  comments 
formats

MicroTransponder’s Injectable Stimulators

    MicroTransponder was founded in Dallas, TX in  2007 when it licensed technology developed at University of Texas in Dallas (UTD) by Larry Cauller, who heads the cortical connections lab. The first wireless transponder was developed under a DARPA Revolutionizing Prosthetics grant to create a bi-directional neural interface for a prosthetic hand.

 
 Share on Facebook Share on Twitter Share on Reddit Share on LinkedIn
Comments Off on MicroTransponder’s Injectable Stimulators  comments 
formats

EnteroMedics’ Maestro RC Vagus Nerve Stimulator for Obesity Management

EnteroMedics Inc. was founded in St. Paul, MN in 2002 to develop a platform for vagus-nerve stimulation, primarily for obesity management.  In March 2011 EnteroMedics received the CE Mark for its second-generation system – the Maestro RC. The EnteroMedics Maestro RC device delivers VBLOC® vagal blocking therapy to through laparoscopically implanted leads to intermittently block the vagus nerves using

 
 Share on Facebook Share on Twitter Share on Reddit Share on LinkedIn
1 Comment  comments